| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/13/2009 | EP2057142A2 Method for the preparation of n-piperidinyl-benzodiazepines having cgrp-antagonistic activity |
| 05/13/2009 | EP2057141A1 Pyrimidone compounds as gsk-3 inhibitors |
| 05/13/2009 | EP2057140A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 05/13/2009 | EP2057127A1 Hydantoin derivatives useful as antibacterial agents |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | EP2057123A1 Anthrapyridone compounds |
| 05/13/2009 | EP1711485B1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 05/13/2009 | EP1678135B1 Process for the preparation of n-amino substituted heterocyclic compounds |
| 05/13/2009 | EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 05/13/2009 | EP1299388B1 Variolin derivatives as anti-cancer agents |
| 05/13/2009 | EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432277A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432276A Quinoline derivatives |
| 05/13/2009 | CN101432275A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432274A Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2009 | CN101432268A Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor |
| 05/13/2009 | CN101432265A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432264A Salts with CRTH2 antagonist activity |
| 05/13/2009 | CN101432263A Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432262A Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432261A N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 05/13/2009 | CN101429232A Hcv protease inhibitors |
| 05/13/2009 | CN101429192A Novel method for producing chiral sulfoxide derivant |
| 05/13/2009 | CN101429191A Uses of substituted tetrahydrochysene isoquinoline derivant |
| 05/13/2009 | CN100486976C Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 05/13/2009 | CN100486975C Novel anthranilamide insecticides |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/12/2009 | US7531668 2-arylcarboxamide-nitrogenous heterocycle compound |
| 05/12/2009 | US7531666 Forming compounds such as Omeprazole, Lansoprazole, Pantoprazole and Rabeprazole by oxidizing the corresponding sulfides in the presence of an alkali metal tungstate at 10-50 degrees C.; commercial mass production under mild reaction conditions; by-product inhibition; simple purification |
| 05/12/2009 | US7531665 Kinase inhibitors for the treatment of disease |
| 05/12/2009 | US7531664 Having at least one sterically hindered nitroxyl, hydroxylamine or hydrocarbyloxyamine moiety and at least one conventional organohalogen or organophosphorus flame retardant moiety: 1-cyclohexyloxy-2,2,6,6-tetramethyl-4-piperidinyl diphenyl phosphate; fireproofing organic polymer substrates |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531656 Synthesis of gatifloxacin |
| 05/12/2009 | US7531566 Anti-inflammatory medicaments |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531558 Carboxamide derivatives |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531554 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531529 Metabotropic glutamate (mGluR5) receptor mediated disorders; genitourinary diseases; containing pyridin-4-ylethynyl functionality |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | CA2428604C Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 05/12/2009 | CA2419178C Cytokine production inhibitor |
| 05/12/2009 | CA2402742C Method of treating or inhibiting colonic polyps |
| 05/12/2009 | CA2395458C Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 05/12/2009 | CA2361402C Bis-sulfonamides |
| 05/12/2009 | CA2324921C Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections |
| 05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009059162A1 Cytokine inhibitors |
| 05/07/2009 | WO2009058653A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 05/07/2009 | WO2009058348A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | WO2009058261A1 Modulation of sleep with nr2b receptor antagonists |
| 05/07/2009 | WO2009058120A1 Nicotinic acetylcholine receptor modulators |
| 05/07/2009 | WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/07/2009 | WO2009058051A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057811A2 Heterocyclic compound and pharmaceutical composition thereof |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009057139A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | WO2009056886A1 Pyrimidine derivatives and their use as modulators of fgfr activity |
| 05/07/2009 | WO2009056881A1 Chemical compounds 313 |
| 05/07/2009 | WO2009056707A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056600A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
| 05/07/2009 | WO2009036753A3 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy |
| 05/07/2009 | WO2009030952A3 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 05/07/2009 | WO2009024287A3 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 05/07/2009 | WO2009010789A3 Pyrimidine derivatives 934 |
| 05/07/2009 | WO2009009041A3 Compositions and methods for modulating a kinase cascade |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2008155081A3 Substituted aromatic heterocyclic compounds as fungicides |
| 05/07/2009 | WO2008122858A3 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
| 05/07/2009 | WO2008077555A3 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 05/07/2009 | WO2008032330A3 Improved process for rimonabant |
| 05/07/2009 | WO2008010897A3 Process for making 3-substituted 2-amino-5-halobenzamides |
| 05/07/2009 | WO2007117665A3 Derivatization-enhanced analysis of amino acids and peptides |
| 05/07/2009 | WO2006047277A3 Inhibitors of c-fms kinase |
| 05/07/2009 | US20090118515 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 05/07/2009 | US20090118513 Chemical Compounds |
| 05/07/2009 | US20090118510 Dark coloured azo dyes |
| 05/07/2009 | US20090118509 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives |
| 05/07/2009 | US20090118506 6,11-bridged biaryl macrolides |
| 05/07/2009 | US20090118503 Faah inhibitors |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118336 Pyrazole derivatives and their use as pi3k inhibitors |
| 05/07/2009 | US20090118335 Acid Secretion Inhibitor |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |